Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2012; 18(23): 2966-2972
Published online Jun 21, 2012. doi: 10.3748/wjg.v18.i23.2966
Published online Jun 21, 2012. doi: 10.3748/wjg.v18.i23.2966
Table 1 Baseline characteristics n (%)
| All patients (n = 62) | |
| Male gender | 45 (72.6) |
| Mean age, yr ± SD | 52 ± 9 |
| Mean weight, kg ± SD | 76 ± 14 |
| Mean BMI, kg/m2± SD | 26 ± 4 |
| Abnormal ALT | 54 (90) |
| Abnormal GGT | 36 (67) |
| Mean hemoglobin, g/dL ± SD | 14.8 ± 1.5 |
| HCV RNA | |
| > 600 000 IU/mL | 11 (28) |
| METAVIR fibrosis score | |
| F2 | 20 (34) |
| F3 | 11 (19) |
| F4 | 23 (39) |
| Steatosis | |
| < 5% | 13 (21) |
| 5%-30% | 23 (37) |
| > 30% | 26 (42) |
- Citation: Stern C, Martinot-Peignoux M, Ripault MP, Boyer N, Castelnau C, Valla D, Marcellin P. Impact of ribavirin dose on retreatment of chronic hepatitis C patients. World J Gastroenterol 2012; 18(23): 2966-2972
- URL: https://www.wjgnet.com/1007-9327/full/v18/i23/2966.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i23.2966